INTERACTION OF PREGNANCY STEROID-HORMONES AND ZIDOVUDINE IN INHIBITION OF HIV TYPE-1 REPLICATION IN MONOCYTOID AND PLACENTAL HOFBAUER CELLS- IMPLICATIONS FOR THE PREVENTION OF MATERNAL-FETAL TRANSMISSION OF HIV
Aw. Lee et al., INTERACTION OF PREGNANCY STEROID-HORMONES AND ZIDOVUDINE IN INHIBITION OF HIV TYPE-1 REPLICATION IN MONOCYTOID AND PLACENTAL HOFBAUER CELLS- IMPLICATIONS FOR THE PREVENTION OF MATERNAL-FETAL TRANSMISSION OF HIV, AIDS research and human retroviruses, 13(14), 1997, pp. 1235-1242
Zidovudine (AZT) has been shown to reduce maternal-fetal transmission
of HTV-1 by more than two-thirds in a variety of clinical settings. Ho
wever, the mechanism of action of AZT in this setting is unclear. Supp
ression of vertical transmission has occurred in the absence of ail im
pact on maternal plasma viremia and no lower threshold of viral load f
or such transmission has been identified. We hypothesized that augment
ation of the anti-HIV effect of AZT may occur locally, at the maternal
-fetal interface. We report that the pregnancy hormone progesterone at
broad concentrations has little effect on acute HIV-1 infection of a
monocytic cell line or primary peripheral blood cells. However, the co
mbination of physiologic concentrations of progesterone (10(-7) to 10(
-6) M) and low-dose AZT (10(-8) to 10(-9) M) produced markedly synergi
stic inhibition of HIV-1 replication within acutely infected monocytic
cell lines (U937), and additive inhibition of HIV-1 growth within chr
onically infected monocytic cells (U1) and primary placental macrophag
es (Hofbauer cells). Anti-HIV effects were not seen with another pregn
ancy steroid hormone, estrogen. In terms of possible mechanisms of act
ion for progesterone, we demonstrated that it incompletely suppressed
fat activation of long terminal repeat (LTR)-driven gene expression in
monocytic cells. However, the progesterone-mediated suppession of tat
activation was not affected by mutation of the three consensus proges
terone/androgen/glucocorticoid response elements within the HIV-1 LTR,
previously shown by our group to be involved in glucocorticoid-mediat
ed suppression of LTR-driven transcription. It is likely that progeste
rone suppresses LTR-driven gene expression through a nontranscriptiona
l mechanism, and augments the efficacy of AZT through enhancement of i
ts phosphorylation.